SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma

Zhang,Rongrong; Zhu,Haiyan; Yuan,Yufang; Wang,Yun; Tian,Zhaofang

doi:10.3892/or.2020.7776

SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma

Authors:
- Rongrong Zhang
- Haiyan Zhu
- Yufang Yuan
- Yun Wang
- Zhaofang Tian
View Affiliations

Affiliations: Department of Pediatrics, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu 223300, P.R. China
Published online on: September 22, 2020 https://doi.org/10.3892/or.2020.7776
Pages: 2021-2030
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The main purpose of the present study was to elucidate the role of sperm‑associated antigen 6 (SPAG6) in the occurrence and development of Burkitt lymphoma (BL) and explore the underlying molecular mechanisms. A correlation was observed between the expression of SPAG6 and the prognosis of patients with lymphoma using The Cancer Genome Atlas (TCGA) database analysis. It was demonstrated that the levels of SPAG6 in BL cells were higher compared with that in IM‑9 cells by reverse transcription‑PCR and western blot assays. Moreover, silencing of SPAG6 significantly decreased proliferation and increased apoptosis of Daudi and Raji cells, whereas SPAG6 overexpression exerted the opposite effects on CA46 and NAMALWA cells. When investigating the possible mechanism, it was first observed that the level of phosphatase and tensin homolog (PTEN) protein was significantly increased, while that of phosphorylated (p‑)AKT protein was markedly reduced in the SPAG6‑knockdown group compared with the blank control group in Daudi and Raji cells by western blot analysis. It was further ascertained whether the phosphoinositide 3‑kinase (PI3K)/PTEN/protein kinase B (AKT) pathway mediates the effects of SPAG6 on cell proliferation and apoptosis, and the results demonstrated that silencing of SPAG6 suppressed the viability of Daudi and Raji cells, whereas PTEN knockdown using siRNA or SF1670 (a specific PTEN inhibitor) reversed the inhibitory effect on cell proliferation and the promoting effect on cell apoptosis induced by SPAG6 depletion in vitro as well as in vivo. These data revealed that SPAG6 may promote the proliferation and inhibit the apoptosis of BL cells via the PTEN/PI3K/AKT pathway. The results of the present study suggest that SPAG6 may play a key role in the progression of BL and may be of value as a predictive prognostic biomarker in patients with BL.

View Figures

View References

1	Jaffe ES: The 2008 WHO classification of lymphomas: Implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 523–531. 2009. View Article : Google Scholar : PubMed/NCBI
2	Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T and Bailey S: Burkitt's lymphoma. Lancet. 379:1234–1244. 2012. View Article : Google Scholar : PubMed/NCBI
3	Ferry JA: Burkitt's lymphoma: Clinicopathologic features and differential diagnosis. Oncologist. 11:375–383. 2006. View Article : Google Scholar : PubMed/NCBI
4	Neilson LI, Schneider PA, Van Deerlin PG, Kiriakidou M, Driscoll DA, Pellegrini MC, Millinder S, Yamamoto KK, French CK and Strauss JF III: cDNA cloning and characterization of a human sperm antigen (SPAG6) with homology to the product of the Chlamydomonas PF16 locus. Genomics. 60:272–280. 1999. View Article : Google Scholar : PubMed/NCBI
5	Sapiro R, Kostetskii I, Olds-Clarke P, Gerton GL, Radice GL and Strauss IJ: Male infertility, impaired sperm motility, and hydrocephalus in mice deficient in sperm-associated antigen 6. Mol Cell Biol. 22:6298–6305. 2002. View Article : Google Scholar : PubMed/NCBI
6	Zhang Z, Jones BH, Tang W, Moss SB, Wei Z, Ho C, Pollack M, Horowitz E, Bennett J, Baker ME and Strauss JF III: Dissecting the axoneme interactome: The mammalian orthologue of Chlamydomonas PF6 interacts with sperm-associated antigen 6, the mammalian orthologue of Chlamydomonas PF16. Mol Cell Proteomics. 4:914–923. 2005. View Article : Google Scholar : PubMed/NCBI
7	Lonergan KM, Chari R, Deleeuw RJ, Shadeo A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, et al: Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression. Am J Respir Cell Mol Biol. 35:651–661. 2006. View Article : Google Scholar : PubMed/NCBI
8	Altenberger C, Heller G, Ziegler B, Tomasich E, Marhold M, Topakian T, Müllauer L, Heffeter P, Lang G, End-Pfützenreuter A, et al: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers. Mol Cancer. 16:12017. View Article : Google Scholar : PubMed/NCBI
9	Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A, Pastan I, Wittig S, Pfaffendorf N, Voigt A, et al: Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res. 12:2434–2441. 2006. View Article : Google Scholar : PubMed/NCBI
10	Wang L, Fidler C, Nadig N, Giagounidis A, Della Porta MG, Malcovati L, Killick S, Gattermann N, Aul C, Boultwood J and Wainscoat JS: Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica. 93:994–1000. 2008. View Article : Google Scholar : PubMed/NCBI
11	Yang B, Wang L, Luo X, Chen L, Yang Z and Liu L: SPAG6 silencing inhibits the growth of the malignant myeloid cell lines SKM-1 and K562 via activating p53 and caspase activation-dependent apoptosis. Int J Oncol. 46:649–656. 2015. View Article : Google Scholar : PubMed/NCBI
12	Wang Z, Jensen MA and Zenklusen JC: A practical guide to the cancer genome atlas (TCGA). Methods Mol Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
13	Li Y, Prasad A, Jia Y, Roy SG, Loison F, Mondal S, Kocjan P, Silberstein LE, Ding S and Luo HR: Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood. 117:6702–6713. 2011. View Article : Google Scholar : PubMed/NCBI
14	Li L, Li Y, Que X, Gao X, Gao Q, Yu M, Ma K, Xi Y and Wang T: Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A systematic review and meta-analysis. Sci Rep. 8:62672018. View Article : Google Scholar : PubMed/NCBI
15	Rochford R and Moormann AM: Burkitt's lymphoma. Curr Top Microbiol Immunol. 390:267–285. 2015.PubMed/NCBI
16	Martin GS: Cell signaling and cancer. Cancer Cell. 4:167–174. 2003. View Article : Google Scholar : PubMed/NCBI
17	Adem J, Eray M, Eeva J, Nuutinen U and Pelkonen J: The combination of TRAIL and MG-132 induces apoptosis in both TRAIL-sensitive and TRAIL-resistant human follicular lymphoma cells. Leuk Res. 66:57–65. 2018. View Article : Google Scholar : PubMed/NCBI
18	Jaffe ES and Pittaluga S: Aggressive B-cell lymphomas: A review of new and old entities in the WHO classification. Hematology Am Soc Hematol Educ Program. 2011:506–514. 2011. View Article : Google Scholar : PubMed/NCBI
19	Vervoorts J, Luscher-Firzlaff J and Luscher B: The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem. 281:34725–34729. 2006. View Article : Google Scholar : PubMed/NCBI
20	Waniczek D, Snietura M, Lorenc Z, Nowakowska-Zajdel E and Muc-Wierzgon M: Assessment of PI3K/AKT/PTEN signaling pathway activity in colorectal cancer using quantum dot- conjugated antibodies. Oncol Lett. 15:1236–1240. 2018.PubMed/NCBI
21	Capodanno A, Camerini A, Orlandini C, Baldini E, Resta ML, Bevilacqua G and Collecchi P: Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node- negative breast carcinoma. Hum Pathol. 40:1408–1417. 2009. View Article : Google Scholar : PubMed/NCBI
22	Hamada T, Teraoka M, Imaki J, Ui-Tei K, Ladher RK and Asahara T: Gene expression of Spag6 in chick central nervous system. Anat Histol Embryol. 39:227–232. 2010. View Article : Google Scholar : PubMed/NCBI
23	Yan R, Hu X, Zhang Q, Song L, Zhang M, Zhang Y and Zhao S: Spag6 negatively regulates neuronal migration during mouse brain development. J Mol Neurosci. 57:463–469. 2015. View Article : Google Scholar : PubMed/NCBI
24	Hu X, Yan R, Cheng X, Song L, Zhang W, Li K and Zhao S: The function of sperm-associated antigen 6 in neuronal proliferation and differentiation. J Mol Histol. 47:531–540. 2016. View Article : Google Scholar : PubMed/NCBI
25	Mulaw MA, Krause A, Deshpande AJ, Krause LF, Rouhi A, La Starza R, Borkhardt A, Buske C, Mecucci C, Ludwig WD, et al: CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia. 26:1012–1019. 2012. View Article : Google Scholar : PubMed/NCBI
26	Steinbach D, Bader P, Willasch A, Bartholomae S, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D and Gruhn B: Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. Clin Cancer Res. 21:1353–1359. 2015. View Article : Google Scholar : PubMed/NCBI
27	Gonzalvez F and Ashkenazi A: New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29:4752–4765. 2010. View Article : Google Scholar : PubMed/NCBI
28	Li X, Yang B, Wang L, Chen L, Luo X and Liu L: SPAG6 regulates cell apoptosis through the TRAIL signal pathway in myelodysplastic syndromes. Oncol Rep. 37:2839–2846. 2017. View Article : Google Scholar : PubMed/NCBI
29	Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY and Chiang CW: Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem. 283:1882–1892. 2008. View Article : Google Scholar : PubMed/NCBI
30	Ramezani A, Nikravesh H and Faghihloo E: The roles of FOX proteins in virus-associated cancers. J Cell Physiol. 234:3347–3361. 2019. View Article : Google Scholar : PubMed/NCBI
31	Jiang M, Chen Y, Deng L, Luo X, Wang L and Liu L: Upregulation of SPAG6 in myelodysplastic syndrome: Knockdown inhibits cell proliferation via AKT/FOXO Signaling Pathway. DNA Cell Biol. 38:476–484. 2019. View Article : Google Scholar : PubMed/NCBI
32	Di Cristofano A and Pandolfi PP: The multiple roles of PTEN in tumor suppression. Cell. 100:387–390. 2000. View Article : Google Scholar : PubMed/NCBI
33	Zhao L, Shan Y, Liu B, Li Y and Jia L: Retraction note: Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML. Cell Death Dis. 11:1212020. View Article : Google Scholar : PubMed/NCBI
34	Yin J, Li X, Zhang Z, Luo X, Wang L and Liu L: SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo. Int J Oncol. 53:297–306. 2018.PubMed/NCBI
35	Gehringer F, Weissinger SE, Moller P, Wirth T and Ushmorov A: Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma. Leukemia. 34:857–871. 2020. View Article : Google Scholar : PubMed/NCBI
36	Kim AH, Khursigara G, Sun X, Franke TF and Chao MV: Akt phosphorylates and negatively regulates apoptosis signal- regulating kinase 1. Mol Cell Biol. 21:893–901. 2001. View Article : Google Scholar : PubMed/NCBI